Tag Archives: biosimilar

Biologic products are drugs that have regulation by the United States Food and Drug Administration. They have utility to diagnose, prevent, treat and cure medical diseases and conditions. They are usually large and complex molecules and are harder to characterize than small molecule drugs. Common and familiar biologics include etanercept (Enbrel®), infliximab (Remicade®), adalimumab (Humira®), […]